Retrograde signalling by endocannabinoids

Handbook of Experimental Pharmacology

Volumn 168, Issue , 2005, Pages 367-383

  Vaughan, C W ^a   Christie, M J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Endocannabinoid; mGluR; Retrograde signalling; Synaptic transmission; TRP

Indexed keywords

EID: 85099485840     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-26573-2_12     Document Type: Article

References (61)

1. Al-Hayani A, Wease KN, Ross RA, Pertwee RG, Davies SN (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41:1000-1005
2. Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Prog Neurobiol 68:247-286
3. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-Arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322:671-677
4. Brown SP, Brenowitz SD, RegehrWG (2003) Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids.NatNeurosci 6:1048-1057
5. Carlson G, Wang Y, Alger BE (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5:723-724
6. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability. Neuron 38:461-472
7. Choi S, Lovinger DM (1997) Decreased frequency but not amplitude of quantal synaptic responses associatedwith expression of corticostriatal long-Termdepression. JNeurosci 17:8613-8620
8. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237
9. Cravatt BF, Lichtman AH (2003) Fatty acid amide hydrolase: An emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7:469-475
10. Di Marzo V, Bisogno T, De Petrocellis L (2001) Anandamide: Some like it hot. Trends Pharmacol Sci 22:346-349
11. Diana MA, Marty A (2003) Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. J Neurosci 23:5906-5918
12. Diana MA, Levenes C, Mackie K, Marty A (2002) Short-Term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J Neurosci 22:200-208
13. Doherty J, Dingledine R (2003) Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr Opin Pharmacol 3:46-53
14. Engelman HS, MacDermott AB (2004) Presynaptic ionotropic receptors and control of transmitter release. Nat Rev Neurosci 5:135-145
15. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066
16. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-Term depression in the striatum. Nat Neurosci 5:446-451
17. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG(2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100:4269-4274
18. Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA (2003) Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol 90:55-64
19. Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: Consensus and controversy. Br J Pharmacol 140:802-808
20. Hoffman AF, Oz M, Caulder T, Lupica CR (2003a) Functional tolerance and blockade of long-Term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J Neurosci 23:4815-4820
21. Hoffman AF, Riegel AC, Lupica CR (2003b) Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. Eur J Neurosci 18:524-534
22. Huang YC, Wang SJ, Chiou LC, Gean PW (2003) Mediation of amphetamine-induced longterm depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J Neurosci 23:10311-10320
23. Jennings EA, Vaughan CW, Roberts LA, Christie MJ (2003) The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J Physiol (Lond) 548:121-129
24. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D(2003)Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
25. Kim J, Isokawa M, Ledent C, Alger BE(2002)Activationofmuscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22:10182-10191
26. Kreitzer AC, Regehr WG (2001a) Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174
27. Kreitzer AC, Regehr WG (2001b) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727
28. Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34:787-796
29. Levenes C, Daniel H, Soubrie P, Crepel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-Termdepression in rat cerebellar Purkinje cells. J Physiol (Lond) 510:867-879
30. Llano I, Leresche N, Marty A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565-574
31. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-475
32. Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, Mercuri NB (2003) Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci 23:3136-3144
33. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang JR, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B(2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
34. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24:53-62
35. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, Szallasi A (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655-3660
36. Morisset V, Ahluwalia J, Nagy I, Urban L (2001) Possible mechanisms of cannabinoidinduced antinociception in the spinal cord. Eur J Pharmacol 429:93-100
37. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of long-Term potentiation by delta-9-Tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 19:663-672
38. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals fromdepolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738
39. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M (2002) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15:953-961
40. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-5305
41. Petrocellis LD, Cascio MG, Marzo VD (2004) The endocannabinoid system: A general view and latest additions. Br J Pharmacol 141:765-774
42. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884
43. Pitler TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122-4132
44. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-Term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99:8384-8388
45. Ronesi J, Gerdeman GL, Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-Termdepression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24:1673-1679
46. Rouach N, Nicoll RA (2003) Endocannabinoids contribute to short-Term but not long-Term mGluR-induced depression in the hippocampus. Eur J Neurosci 18:1017-1020
47. Sasamura T, Sasaki M, Tohda C, Kuraishi Y (1998) Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport 9:2045-2048
48. Schlicker E, Kathmann M(2001)Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572
49. Schmid HHO (2000) Pathways and mechanisms of N-Acylethanolamine biosynthesis: Can anandamide be generated selectively? Chem Phys Lipids 108:71-87
50. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334
51. Sjostrom PJ, Turrigiano GG, Nelson SB (2003) Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39:641-654
52. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-Term potentiation. Nature 388:773-778
53. Sugiura T, Kobayashi Y, Oka S, Waku K (2002) Biosynthesis and degradation of anandamide and2-Arachidonoylglycerolandtheir possiblephysiological significance.Prostaglandins Leukot Essent Fatty Acids 66:173-192
54. Terranova JP, Michaud JC, Le Fur G, Soubrie P (1995) Inhibition of long-Term potentiation in rat hippocampal slices by anandamide and WIN55212-2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 352:576-579
55. Trettel J, Levine ES (2003) Endocannabinoids mediate rapid retrograde signaling at interneuron? pyramidal neuron synapses of the neocortex. J Neurophysiol 89:2334-2338
56. Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC188
57. Vaughan CW, Connor M, Bagley EE, Christie MJ (2000) Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57:288-295
58. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592
59. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462
60. Yanovsky Y, Mades S, Misgeld U (2003) Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neuroscience 122:317-328
61. Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M(2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22:1690-1697